FarFaR - Pharmacy Repository
University of Belgrade, Faculty of Pharmacy
    • English
    • Српски
    • Српски (Serbia)
  • English 
    • English
    • Serbian (Cyrilic)
    • Serbian (Latin)
  • Login
View Item 
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
  •   FarFaR
  • Pharmacy
  • Radovi istraživača / Researchers’ publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Circulating sTWEAK improves the prediction of coronary artery disease

Authorized Users Only
2009
Authors
Jelić-Ivanović, Zorana
Bujisić, Nada
Spasić, Slavica
Bogavac-Stanojević, Nataša
Spasojević-Kalimanovska, Vesna
Kotur-Stevuljević, Jelena
Article (Published version)
Metadata
Show full item record
Abstract
Objectives: Decreased concentrations of circulating soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) were recently reported to be associated with atherosclerosis, but there are still no data concerning its predictive performance. Design and methods: The current cross-sectional study investigates the potential of the novel atherosclerotic biomarker for the prediction of coronary artery disease (CAD). Serum sTWEAK was measured by ELISA in 76 CAD patients and 82 CAD-free subjects. Results: Serum sTWEAK concentrations were significantly lower in the patients (534.5 +/- 110.9 mu g/L) than in the controls (688.1 +/- 150.0 mu g/L, p lt 0.001), even after adjusting for different confounders (p lt 0.001). The areas under ROC curves (AUC)s calculated for logistic regression models that included different known risk factors were significantly increased when sTWEAK was added to the corresponding model (p = 0.011-0.035). Conclusions: The measurement of serum sTWEAK concentr...ations improves the prediction of CAD based on existing biomarkers.

Keywords:
Atherosclerosis / Risk factors / Coronary artery disease / ROC curve analysis / Biomarkers / sTWEAK
Source:
Clinical Biochemistry, 2009, 42, 13-14, 1381-1386
Publisher:
  • Pergamon-Elsevier Science Ltd, Oxford
Projects:
  • Ispitivanje biohemijskih i genetičkih faktora rizika kao uzročnika i markera ateroskleroze i drugih oboljenja: analitički i klinički aspekti (RS-145036)

DOI: 10.1016/j.clinbiochem.2009.06.001

ISSN: 0009-9120

PubMed: 19505454

WoS: 000272261800008

Scopus: 2-s2.0-69249205389
[ Google Scholar ]
32
31
URI
http://farfar.pharmacy.bg.ac.rs/handle/123456789/1210
Collections
  • Radovi istraživača / Researchers’ publications
Institution
Pharmacy

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB
 

 

All of DSpaceInstitutionsAuthorsTitlesSubjectsThis institutionAuthorsTitlesSubjects

Statistics

View Usage Statistics

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB